Bridging Academia and Industry to Accelerate Drug Development and Translation
We are committed to integrating AI-driven design with key materials and process development technologies to accelerate the translation of new drugs from research and development to clinical application.
We integrate value-added medicinal chemistry, key materials, and AI-driven computational technologies to help shorten drug development timelines, reduce development costs, and accelerate the advancement of drug candidates.
We provide customized synthesis services for small-molecule drug development, accelerating the advancement of new drugs from R&D to preclinical development.
Developing key drug materials and functional molecular libraries to accelerate drug candidate design and development.
Integrating AI-driven drug design and predictive algorithms with big-data analytics to enhance drug screening efficiency.
